1 asset in IDH-Mutant And 1p/19q-Codeleted Oligodendroglioma
Therapeutic assets addressing IDH-Mutant And 1p/19q-Codeleted Oligodendroglioma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Safusidenib IDH-Mutant And 1p/19q-Codeleted Oligodendroglioma | Nuvation Bio Inc. | P3 | B (60) |